Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Clinical trial NCT03216343 · COMPLETED
Trial details
- NCT number
- NCT03216343
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2022-11-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.